Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy

Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy

Abstract Background Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause of infant death after malaria. RSV infection occurs in almost all the infants before...

Full description

Bibliographic Details
Main Authors: Melania Dovizio, Chiara Veronesi, Fausto Bartolini, Arturo Cavaliere, Stefano Grego, Romina Pagliaro, Cataldo Procacci, Loredana Ubertazzo, Lorenzo Bertizzolo, Barbara Muzii, Salvatore Parisi, Valentina Perrone, Eugenio Baraldi, Elena Bozzola, Fabio Mosca, Luca Degli Esposti
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Italian Journal of Pediatrics
Subjects:
Children
Monoclonal antibodies
Infants
Prevention of RSV
Real-world evidence
Respiratory syncytial virus
Online Access:https://doi.org/10.1186/s13052-024-01628-7

Internet

https://doi.org/10.1186/s13052-024-01628-7

Similar Items